Navigation Links
Tumor Eradication Article Published by Cancer Research
Date:11/12/2007

he Institute of Biochemistry and Institute for Molecular Infection Biology at the University of Wurzburg in Germany.

Background

GL-ONC1 is a genetically stable oncolytic virus strain designed to locate, enter, colonize and destroy cancer cells without harming healthy tissues or organs. GL-ONC1 is based on vaccinia virus, which was used safely in millions of people as the vaccine against smallpox. Scientists at Genelux have modified this virus to increase its safety, tumor selectivity and anti-tumor activity without limiting its ability to replicate in cancer cells. GL-ONC1 also carries a unique fusion protein designed to provide non-invasive, real-time imaging capabilities, including tumor diagnosis and localization, microscopic analysis of tumor biopsies, cancer staging and follow-up treatment monitoring.

The safety and efficacy demonstrated in preclinical studies, along with vaccinia virus' well-documented safety record as a vaccine against smallpox, make GL-ONC1 a promising candidate for clinical trials. Clinical trials are expected to begin in the near future in the U.S. and Europe.

To read the abstract, visit: http://cancerres.aacrjournals.org/cgi/content/abstract/67/20/10038. For company information, visit: http://www.genelux.com.

Statements made about Genelux Corporation, other than statements of historical fact, reflect Management's current beliefs and assumptions founded on the data and information currently available to us. Statements of the company's progress, results, timing of pre-clinical and clinical trials and projections for product pipelines are examples of forward-looking statements. By definition, such undertakings involve risks, uncertainties and assumptions, and are subject to a number of such factors that could cause actual results to differ substantially from statements
'/>"/>

SOURCE Genelux Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
2. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
3. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
4. Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
5. Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors
6. Pharmion and MethylGene Initiate Phase One Combination Clinical Trial with MGCD0103 and Taxotere(R) in Patients with Solid Tumors
7. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
8. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
9. Updated Phase 1 Data for Exelixis XL184 Demonstrate Pharmacodynamic and Clinical Anti-Tumor Activity
10. Kosan Presents Phase 1 Data Showing Antitumor Activity and Safety Profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting
11. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 26, 2014  Aridis Pharmaceuticals, Inc., a biopharmaceutical ... for infectious diseases, announced today the addition of ... key opinion leader in the areas of pneumonia ... Founder and Chief Executive Officer, ... Opal,s extensive experience investigating bacterial toxins and key ...
(Date:11/26/2014)... WASHINGTON and NEW YORK ... 2014 As the leading distributor of market ... a new research report by IQ4I Research and Consultancy ... To learn more about IQ4I Research visit: ... Active Pharmaceutical Ingredients Global Market – Forecast ...
(Date:11/26/2014)... Nov. 25, 2014  At the American Dental Association,s ... this October, KaVo Kerr Group was honored to be ... attendees the opportunity to see and test the Best ... leaders deliver lectures on the latest developments in dental ... the new DEXIS CariVu Caries Detection Device and Kerr ...
Breaking Medicine Technology:Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3
... SUNNYVALE, Calif., Nov. 10, 2011 Accuray Incorporated (Nasdaq: ... that its president and chief executive officer, Euan S. Thomson, ... 8th Annual Healthcare Conference in New York City on Tuesday ... Thomson is also scheduled to present at the Stephens Fall ...
... healthcare distributors continue to provide increased value to the ... challenges in the pharmaceutical industry, according to The ... released by the Center for Healthcare Supply Chain Research. ... Healthcare Distribution Management Association (HDMA).   ...
Cached Medicine Technology:Pharmaceutical Distributors Continue to Deliver Operational Efficiencies and Value to U.S. Healthcare System Amidst Economic and Regulatory Challenges 2Pharmaceutical Distributors Continue to Deliver Operational Efficiencies and Value to U.S. Healthcare System Amidst Economic and Regulatory Challenges 3Pharmaceutical Distributors Continue to Deliver Operational Efficiencies and Value to U.S. Healthcare System Amidst Economic and Regulatory Challenges 4
(Date:11/28/2014)... November 28, 2014 Dr. Paul Vitenas, one of ... a Glitter & Glow Holiday Event for those in the area ... at his practice. Glitter & Glow will take place on December ... new location in the heart of Houston at 4208 Richmond Ave. ... and hope that you will come and celebrate the season with ...
(Date:11/28/2014)... 2014 Written and narrated by award winning ... releases the “The Happiest Man In the World: Life ... of how and why Project C.U.R.E. came to be. , ... Josie and the Reverend Richard W. Jackson, Dr. Jackson exceeded ... 30, but realized that he wasn’t happy. Prompted by this ...
(Date:11/28/2014)... Alex Kramer HealthDay Reporter , ... in the kitchen, through cooking classes or at home, may ... a recent review. Cooking programs and classes for children ... to the new research. And, although the review didn,t look ... such programs might help children develop long-lasting healthy habits. ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 An inventor and ... light on a patient’s filling and it was almost impossible ... ergonomic curing light," she said. , The patent-pending Access Light ... eases access to areas of the mouth, as well as ... efficiency and safety. Easy to use and clean, it also ...
(Date:11/28/2014)... New York, New York (PRWEB) November 28, 2014 ... lawsuits ( http://www.consumerinjurylawyers.com/stryker-rejuvenate/stryker-hip-lawsuits/ ) have now been filed ... pair of recalled metal implants, Bernstein Liebhard LLP ... November 18th in Bergen County Superior Court reflects ... and ABG II modular-neck hip stems, which were ...
Breaking Medicine News(10 mins):Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Want Kids to Eat Better? Get Them Cooking 2Health News:Want Kids to Eat Better? Get Them Cooking 3Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 2Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 3
... of OTC drugs grew by 2.4% from $17.8 million ... the latest research in Nonprescription Drugs USA 2008: ... research firm Kline & Company.Private-label OTC medicines were up ... and allergy medicines posted the highest growth last year, ...
... sensitive gradiometer instrument has been switched on and is ... is specifically designed to measure Earth,s gravity field with ... we have seen from the gradiometer from the moment ... working in very good health and provide meaningful data," ...
... Gentiva Health Services, Inc. (Nasdaq: GTIV ), ... that it has scheduled a conference call and web cast ... discuss operating results for the first quarter ended March 29, ... morning of April 30 before pre-market trading. The conference call ...
... Super Bowl MVP Eli Manning , who serves ... business and corporate leaders on Monday, April 6, for a private ... and a member of the March of Dimes NY Division Board ... 3 Times Square, in New York. CBS 2 News Co-Anchor, Maurice ...
... ATLANTA, April 8 Amoena, the worldwide ... the introduction of The Hannah Collection, the ... E and Aloe to ease discomfort after ... )(Photo: http://www.newscom.com/cgi-bin/prnh/20090408/CL96087 ...
... MYL ) today announced the settlement of all ... generic version of Schering- Plough,s Clarinex(R) allergy medication. This ... of New Jersey since September 2006.Pursuant to the settlement, ... 5 mg, in the U.S. on July 1, 2012, ...
Cached Medicine News:Health News:Private-label OTC Drugs Post Solid Gains in 2008, According to Kline 2Health News:Private-label OTC Drugs Post Solid Gains in 2008, According to Kline 3Health News:GOCE's 'heart' starts beating 2Health News:Gentiva(R) Health Services Schedules First Quarter Earnings Call and Web Cast for Thursday, April 30, 2009 2Health News:Gentiva(R) Health Services Schedules First Quarter Earnings Call and Web Cast for Thursday, April 30, 2009 3Health News:Eli Manning and Top Corporate Leaders Rally to Help Save Babies 2Health News:Amoena Introduces First Post Surgical Garments With Vitamin E & Aloe to Help Soothe and Comfort After Breast Surgery 2Health News:Mylan Announces Clarinex(R) Settlement Agreement 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: